199 related articles for article (PubMed ID: 1507584)
21. Effects of ATP-sensitive K+ channel openers on pacemaker activity in isolated single rabbit sino-atrial node cells.
Satoh H
J Cardiovasc Pharmacol; 1993 Dec; 22(6):863-8. PubMed ID: 7509906
[TBL] [Abstract][Full Text] [Related]
22. Vasodilatation of canine cerebral arteries by nicorandil, pinacidil and lemakalim.
Zhang H; Stockbridge N; Weir B; Vollrath B; Cook D
Gen Pharmacol; 1992 Mar; 23(2):197-201. PubMed ID: 1353469
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of KRN2391, a novel vasodilator, compared with those of cromakalim, pinacidil and nifedipine in rat aorta.
Kashiwabara T; Nakajima S; Izawa T; Fukushima H; Nishikori K
Eur J Pharmacol; 1991 Apr; 196(1):1-7. PubMed ID: 1678711
[TBL] [Abstract][Full Text] [Related]
24. Cromakalim and pinacidil dilate small mesenteric arteries but not small cerebral arteries.
McCarron JG; Quayle JM; Halpern W; Nelson MT
Am J Physiol; 1991 Aug; 261(2 Pt 2):H287-91. PubMed ID: 1908639
[TBL] [Abstract][Full Text] [Related]
25. The negative inotropic effect of nicorandil is independent of cyclic GMP changes: a comparison with pinacidil and cromakalim in canine atrial muscle.
Yanagisawa T; Hashimoto H; Taira N
Br J Pharmacol; 1988 Oct; 95(2):393-8. PubMed ID: 2852521
[TBL] [Abstract][Full Text] [Related]
26. K(+)-channel openers for relaxation of isolated penile erectile tissue from rabbit.
Holmquist F; Andersson KE; Fovaeus M; Hedlund H
J Urol; 1990 Jul; 144(1):146-51. PubMed ID: 2359166
[TBL] [Abstract][Full Text] [Related]
27. Demonstration of the potassium channel opening activity of GYKI-12743 by 86Rb+ efflux studies.
Bakonyi A; Horváth EJ
Acta Physiol Hung; 1994; 82(4):295-300. PubMed ID: 7785439
[TBL] [Abstract][Full Text] [Related]
28. Specific antagonism by glibenclamide of negative inotropic effects of potassium channel openers in canine atrial muscle.
Satoh E; Yanagisawa T; Taira N
Jpn J Pharmacol; 1990 Oct; 54(2):133-41. PubMed ID: 2150209
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
[TBL] [Abstract][Full Text] [Related]
30. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
Grover GJ; McCullough JR; Henry DE; Conder ML; Sleph PG
J Pharmacol Exp Ther; 1989 Oct; 251(1):98-104. PubMed ID: 2507775
[TBL] [Abstract][Full Text] [Related]
31. [The vasospasmolytic effects of nicorandil, cromakalim and pinacidil on 3,4-diaminopyridine-induced phasic contractions in canine coronary arteries as an experimental vasospasm model].
Kamijo T; Tomaru T; Miwa A; Nakamura F; Kido H; Sugimoto T; Uchida Y
Nihon Yakurigaku Zasshi; 1992 Oct; 100(4):317-27. PubMed ID: 1446882
[TBL] [Abstract][Full Text] [Related]
32. Effects of the potassium channel openers cromakalim and pinacidil on catecholamine secretion and calcium mobilization in cultured bovine adrenal chromaffin cells.
Masuda Y; Yoshizumi M; Ishimura Y; Katoh I; Oka M
Biochem Pharmacol; 1994 May; 47(10):1751-8. PubMed ID: 7515621
[TBL] [Abstract][Full Text] [Related]
33. K(+)-channel openers: new antihypertensive drugs?
Haeusler G
Clin Physiol Biochem; 1990; 8 Suppl 2():46-56. PubMed ID: 2095310
[TBL] [Abstract][Full Text] [Related]
34. Analysis of cromakalim-, pinacidil-, and nicorandil-induced relaxation of the 5-hydroxytryptamine precontracted rat isolated basilar artery.
Ksoll E; Parsons AA; Mackert JR; Schilling L; Wahl M
Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):377-83. PubMed ID: 1830131
[TBL] [Abstract][Full Text] [Related]
35. The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.
McPherson GA; Stork AP
Br J Pharmacol; 1992 Jan; 105(1):51-8. PubMed ID: 1534504
[TBL] [Abstract][Full Text] [Related]
36. Effects of potassium channel openers in isolated human cerebral arteries.
Hempelmann RG; Barth HL; Mehdorn HM; Pradel RH; Ziegler A
Neurosurgery; 1995 Dec; 37(6):1146-53. PubMed ID: 8584155
[TBL] [Abstract][Full Text] [Related]
37. Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs.
Giudicelli JF; la Rochelle CD; Berdeaux A
J Pharmacol Exp Ther; 1990 Nov; 255(2):836-42. PubMed ID: 2173761
[TBL] [Abstract][Full Text] [Related]
38. Effect of three novel K+ channel openers, cromakalim, pinacidil and nicorandil on allergic reaction and experimental asthma.
Nagai H; Kitagaki K; Goto S; Suda H; Koda A
Jpn J Pharmacol; 1991 May; 56(1):13-21. PubMed ID: 1831870
[TBL] [Abstract][Full Text] [Related]
39. Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil.
Wilson C; Coldwell MC; Howlett DR; Cooper SM; Hamilton TC
Eur J Pharmacol; 1988 Aug; 152(3):331-9. PubMed ID: 2851450
[TBL] [Abstract][Full Text] [Related]
40. Lack of effect of potassium channel openers on ATP-modulated potassium channels recorded from rat ventromedial hypothalamic neurones.
Sellers AJ; Boden PR; Ashford ML
Br J Pharmacol; 1992 Dec; 107(4):1068-74. PubMed ID: 1467829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
